U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644910) titled 'Nudging Preventive Screening Via Message Framing and Bundling' on June 08.
Brief Summary: This study is a randomized controlled field experiment embedded in the medical institution Early Diagnosis Program in Chile. Participants with two exams pending (a cancer screening test and a chronic disease test for diabetes and dyslipidemia) will be randomly assigned across a 3 x 3 factorial design: three message framing conditions (Basic, Risk/Importance, Peace of Mind) crossed with three exam-type conditions (cancer screening only, chronic disease test only, or both exams). Participants with only a cancer screening pending will be assigned ...